Two HDAC inhibitors, belinostat and romidepsin, were reported to effectively enhance DNA lesion induced by etoposide in SCLC cells only when either of the inhibitors and the drug were added simultaneously [192]. Here, HDAC9 is linked to small cell lung carcinoma.